Central Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $721K | Sell |
5,709
-374
| -6% | -$49.3K | 0.1% | 122 |
|
|
2026
Q1 | $848K | Sell |
6,083
-133
| -2% | -$18.6K | 0.13% | 110 |
|
|
2025
Q4 | $763K | Sell |
6,216
-611
| -9% | -$74.3K | 0.12% | 120 |
|
|
2025
Q3 | $758K | Sell |
6,827
-25
| -0.4% | -$2.84K | 0.12% | 125 |
|
|
2025
Q2 | $760K | Sell |
6,852
-125
| -2% | -$13.3K | 0.12% | 119 |
|
|
2025
Q1 | $782K | Sell |
6,977
-3,114
| -31% | -$321K | 0.13% | 115 |
|
|
2024
Q4 | $932K | Buy |
10,091
+49
| +0.5% | +$4.41K | 0.14% | 98 |
|
|
2024
Q3 | $842K | Sell |
10,042
-416
| -4% | -$31.7K | 0.12% | 119 |
|
|
2024
Q2 | $718K | Sell |
10,458
-1,057
| -9% | -$70.5K | 0.1% | 117 |
|
|
2024
Q1 | $843K | Sell |
11,515
-33,958
| -75% | -$2.61M | 0.12% | 112 |
|
|
2023
Q4 | $3.68M | Buy |
45,473
+1,772
| +4% | +$138K | 0.57% | 54 |
|
|
2023
Q3 | $3.27M | Buy |
43,701
+3,039
| +7% | +$234K | 0.57% | 55 |
|
|
2023
Q2 | $3.13M | Buy |
40,662
+40,383
| +14,474% | +$3.22M | 0.53% | 57 |
|
|
2023
Q1 | $23.1K | Sell |
279
-14
| -5% | -$1.16K | ﹤0.01% | 252 |
|
|
2022
Q4 | $25.2K | Hold |
293
| – | – | ﹤0.01% | 253 |
|
|
2022
Q3 | $18K | Hold |
293
| – | – | ﹤0.01% | 253 |
|
|
2022
Q2 | $18K | Sell |
293
-207
| -41% | -$12.8K | ﹤0.01% | 262 |
|
|
2022
Q1 | $30K | Hold |
500
| – | – | ﹤0.01% | 246 |
|
|
2021
Q4 | $36K | Buy |
+500
| New | +$34.4K | 0.01% | 244 |
|
|
2020
Q4 | – | Sell |
-900
| Closed | -$57K | – | 284 |
|
|
2020
Q3 | $57K | Buy |
900
+700
| +350% | +$48.5K | 0.01% | 192 |
|
|
2020
Q2 | $15K | Buy |
+200
| New | +$15.3K | ﹤0.01% | 211 |
|
|
2017
Q2 | – | Sell |
-830
| Closed | -$56K | – | 292 |
|
|
2017
Q1 | $56K | Sell |
830
-6,641
| -89% | -$467K | 0.01% | 181 |
|
|
2016
Q4 | $535K | Sell |
7,471
-404
| -5% | -$30K | 0.14% | 98 |
|
|
2016
Q3 | $623K | Sell |
7,875
-10,382
| -57% | -$843K | 0.18% | 86 |
|
|
2016
Q2 | $1.52M | Sell |
18,257
-28,175
| -61% | -$2.5M | 0.44% | 64 |
|
|
2016
Q1 | $4.26M | Sell |
46,432
-52
| -0.1% | -$4.69K | 1.19% | 31 |
|
|
2015
Q4 | $4.7M | Buy |
46,484
+4,584
| +11% | +$477K | 1.36% | 21 |
|
|
2015
Q3 | $4.11M | Buy |
41,900
+3,009
| +8% | +$334K | 1.36% | 22 |
|
|
2015
Q2 | $4.55M | Buy |
38,891
+5,600
| +17% | +$612K | 1.45% | 24 |
|
|
2015
Q1 | $3.27M | Buy |
33,291
+5,651
| +20% | +$574K | 1.09% | 36 |
|
|
2014
Q4 | $2.6M | Buy |
27,640
+24,968
| +934% | +$2.58M | 0.89% | 39 |
|
|
2014
Q3 | $284K | Buy |
2,672
+2,020
| +310% | +$198K | 0.11% | 117 |
|
|
2014
Q2 | $49K | Hold |
652
| – | – | 0.02% | 165 |
|
|
2014
Q1 | $46K | Hold |
652
| – | – | 0.02% | 173 |
|
|
2013
Q4 | $49K | Hold |
652
| – | – | 0.02% | 165 |
|
|
2013
Q3 | $41K | Buy |
652
+379
| +139% | +$22.7K | 0.02% | 168 |
|
|
2013
Q2 | $14.5K | Buy |
+273
| New | +$14.2K | 0.01% | 227 |
|
Other funds holding GILD
LMFP
CIM
CGH
CNB
Central Bank & Trust's GILD Position: Q2 2026 in Review
Central Bank & Trust reduced its Gilead Sciences (GILD) stake by 6.1% in Q2 2026, selling an estimated $49.3K and leaving 5,709 shares worth $721K. The position accounts for 0.1% of the portfolio, ranked #122.
Central Bank & Trust first reported a position in GILD in Q2 2013 and has held it in 37 quarters since. The position peaked at $4.7M in Q4 2015. 536 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Central Bank & Trust held 5,709 shares of Gilead Sciences worth $721K as of Q2 2026.
- Central Bank & Trust sold 374 Gilead Sciences shares in Q2 2026, an estimated $49.3K.
- Gilead Sciences made up 0.1% of Central Bank & Trust's portfolio in Q2 2026, its #122 holding.
- Central Bank & Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 37 quarters since.
- Central Bank & Trust's Gilead Sciences position peaked at $4.7M in Q4 2015.
- 536 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Central Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.